ARIAKE JAPAN Co., Ltd. (TYO:2815)

Market Cap	216.57B
Revenue (ttm)	65.40B
Net Income (ttm)	8.21B
Shares Out	31.85M
EPS (ttm)	257.66
PE Ratio	26.39
Forward PE	23.24
Dividend	130.00 (1.94%)
Ex-Dividend Date	Sep 29, 2025

Volume	59,100
Average Volume	41,000
Open	6,710.00
Previous Close	6,710.00
Day's Range	6,660.00 - 6,800.00
52-Week Range	4,435.00 - 6,890.00
Beta	-0.00
RSI	61.24
Earnings Date	Aug 8, 2025

About Theseus Pharmaceuticals

ARIAKE JAPAN Co., Ltd. manufactures, processes, and sells natural seasoning products with extracts from chicken, pork, beef, and other fresh livestock ingredients. It provides chicken bone base soups, ramen soups, chanpon soups, bouillon and consomme products, sauce bases, and Japanese bouillon products; and livestock meat, including beef, pork, and chicken, as well as shrimps, garlic, and seasoning oils. The company also engages in the production, processing, export/import, and sale of agricultural and livestock products, marine products, and ...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1966
• Employees: 1,166
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2815

Financial Performance

In 2024, ARIAKE JAPAN's revenue was 65.40 billion, an increase of 9.03% compared to the previous year's 59.98 billion. Earnings were 8.21 billion, an increase of 11.60%.